Advisornet Financial’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.7K Hold
3,399
﹤0.01% 1303
2026
Q1
$23.1K Hold
3,399
﹤0.01% 1293
2025
Q4
$39.5K Hold
3,399
﹤0.01% 1127
2025
Q3
$39.5K Hold
3,399
﹤0.01% 1102
2025
Q2
$41.9K Hold
3,399
﹤0.01% 1053
2025
Q1
$20.9K Hold
3,399
﹤0.01% 1177
2024
Q4
$27.5K Sell
3,399
-719
-17% -$7.18K ﹤0.01% 1044
2024
Q3
$33.3K Sell
4,118
-2,050
-33% -$11.1K ﹤0.01% 1035
2024
Q2
$26.7K Sell
6,168
-2,200
-26% -$11.2K ﹤0.01% 1009
2024
Q1
$35.5K Sell
8,368
-1,329
-14% -$4.61K ﹤0.01% 914
2023
Q4
$36.5K Hold
9,697
﹤0.01% 905
2023
Q3
$35.9K Sell
9,697
-3,550
-27% -$14.1K ﹤0.01% 874
2023
Q2
$52.5K Hold
13,247
﹤0.01% 798
2023
Q1
$54.8K Buy
13,247
+2,550
+24% +$10.4K 0.01% 775
2022
Q4
$45.1K Hold
10,697
﹤0.01% 819
2022
Q3
$30K Hold
10,697
﹤0.01% 987
2022
Q2
$43K Hold
10,697
﹤0.01% 915
2022
Q1
$59K Buy
10,697
+4,599
+75% +$21.1K ﹤0.01% 908
2021
Q4
$28K Buy
6,098
+4,769
+359% +$23.7K ﹤0.01% 1194
2021
Q3
$6K Hold
1,329
﹤0.01% 1571
2021
Q2
$9K Buy
+1,329
New +$10.6K ﹤0.01% 1435

Other funds holding CRMD

Advisornet Financial's CRMD Position: Q2 2026 in Review

Advisornet Financial held its CorMedix (CRMD) position steady in Q2 2026 at 3,399 shares worth $26.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1303.

Advisornet Financial first reported a position in CRMD in Q2 2021 and has held it in 21 quarters since. The position peaked at $59K in Q1 2022. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Advisornet Financial held 3,399 shares of CorMedix worth $26.7K as of Q2 2026.
  • Advisornet Financial left its CorMedix share count unchanged in Q2 2026.
  • CorMedix made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1303 holding.
  • Advisornet Financial first reported a position in CorMedix in Q2 2021 and has held it in 21 quarters since.
  • Advisornet Financial's CorMedix position peaked at $59K in Q1 2022.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.